-5%
Tablet Manufacturer/Distributor: Square Pharmaceuticals Ltd. Generic Name: Ivabradine 7.5 mg Tablet
Symptomatic treatment of chronic stable angina pectoris in coronary artery disease patients with normal sinus rhythm. Ivabradine is indicated:
- In patients unable to tolerate or with a contra-indication to the use of beta-blockers or
- In combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.
